Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 1188

1.

Effectiveness of pneumococcal conjugate vaccine and rotavirus vaccine introduction into the South African public immunisation programme.

Madhi SA, Bamford L, Ngcobo N.

S Afr Med J. 2014 Mar;104(3 Suppl 1):228-34.

PMID:
24893498
[PubMed - indexed for MEDLINE]
2.

[Pneumococcal meningitis in children under 15 years of age in Misiones (Argentina). Sixteen year's epidemiological surveillance].

Grenón SL, Salvi Grabulosa MC, Regueira MM, Fossati MS, von Specht MH.

Rev Argent Microbiol. 2014 Jan-Mar;46(1):14-23. doi: 10.1016/S0325-7541(14)70042-2. Spanish.

PMID:
24721269
[PubMed - indexed for MEDLINE]
Free Article
3.

Decreasing incidence and changes in serotype distribution of invasive pneumococcal disease in persons aged under 18 years since introduction of 10-valent and 13-valent conjugate vaccines in Portugal, July 2008 to June 2012.

Aguiar SI, Brito MJ, Horacio AN, Lopes JP, Ramirez M, Melo-Cristino J; Portuguese Group for the Study of Streptococcal Infections; Portuguese Study Group of Invasive Pneumococcal Disease of the Paediatric Infectious Disease Society.

Euro Surveill. 2014 Mar 27;19(12):20750.

PMID:
24698140
[PubMed - indexed for MEDLINE]
Free Article
4.

Efficacy and effectiveness of extended-valency pneumococcal conjugate vaccines.

Lee H, Choi EH, Lee HJ.

Korean J Pediatr. 2014 Feb;57(2):55-66. doi: 10.3345/kjp.2014.57.2.55. Epub 2014 Feb 24.

PMID:
24678328
[PubMed]
Free PMC Article
5.

Hospital admission rates for meningitis and septicaemia caused by Haemophilus influenzae, Neisseria meningitidis, and Streptococcus pneumoniae in children in England over five decades: a population-based observational study.

Martin NG, Sadarangani M, Pollard AJ, Goldacre MJ.

Lancet Infect Dis. 2014 May;14(5):397-405. doi: 10.1016/S1473-3099(14)70027-1. Epub 2014 Mar 14.

PMID:
24631222
[PubMed - indexed for MEDLINE]
6.

Regional advisory board position statement on optimal pneumococcal vaccination in adults. Update to 2011 consensus on adult pneumococcal disease: update on optimal pneumococcal vaccination in adults.

Ludwig E, Unal S, Bogdan M, Chlíbek R, Ivanov Y, Kozlov R, Lode H, Mészner Z, Prymula R, Rahav G, Skoczyńska A, Solovic I, Sayiner A.

Cent Eur J Public Health. 2013 Dec;21(4):233-6.

PMID:
24592732
[PubMed - indexed for MEDLINE]
7.

Distance to health services affects local-level vaccine efficacy for pneumococcal conjugate vaccine (PCV) among rural Filipino children.

Root ED, Lucero M, Nohynek H, Anthamatten P, Thomas DS, Tallo V, Tanskanen A, Quiambao BP, Puumalainen T, Lupisan SP, Ruutu P, Ladesma E, Williams GM, Riley I, Simões EA.

Proc Natl Acad Sci U S A. 2014 Mar 4;111(9):3520-5. doi: 10.1073/pnas.1313748111. Epub 2014 Feb 18.

PMID:
24550454
[PubMed - indexed for MEDLINE]
8.

[Pneumococcal disease prevention from early infancy to old age].

Mészner Z.

Orv Hetil. 2014 Feb 16;155(7):243-7. doi: 10.1556/OH.2014.29753. Review. Hungarian.

PMID:
24509352
[PubMed - indexed for MEDLINE]
9.

Incidence of pediatric invasive pneumococcal disease in the Island of Majorca (2008-2010), an area with non-universal vaccination, and estimations of serotype & children population coverage by available conjugate vaccines.

Picazo J, Dueñas J, Ramirez A, Perez AR, Padilla E, Herrero S, Gallegos C, Culebras E, Balseiro C, Mendez C.

BMC Infect Dis. 2013 Oct 29;13:503. doi: 10.1186/1471-2334-13-503.

PMID:
24498901
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Impact of pneumococcal polysaccharide vaccine in people aged 65 years or older.

Menzies RI, Jayasinghe SH, Krause VL, Chiu CK, McIntyre PB.

Med J Aust. 2014 Feb 3;200(2):112-5.

PMID:
24484116
[PubMed - indexed for MEDLINE]
11.

Pneumococcal serotype diversity among adults in various countries, influenced by pediatric pneumococcal vaccination uptake.

Grabenstein JD, Weber DJ.

Clin Infect Dis. 2014 Mar;58(6):854-64. doi: 10.1093/cid/cit800. Epub 2013 Dec 15.

PMID:
24344141
[PubMed - in process]
12.

Serotype distribution and antimicrobial susceptibilities of nasopharyngeal isolates of Streptococcus pneumoniae from healthy children in the 13-valent pneumococcal conjugate vaccine era.

Zuccotti G, Mameli C, Daprai L, Garlaschi ML, Dilillo D, Bedogni G, Faccini M, Gramegna M, Torresani E; PneuMi Study Group (PMSG), Ballerini E, Benincaso A, Bonvissuto M, Bricalli D, Brioschi M, Calloni CS, Camiletti MI, Colella G, De Angelis L, Decarlis S, Di Nello F, Dozzi M, Galli E, Gandini V, Giuliani MG, Laviola F, Loda B, Macedoni M, Mazzucchi E, Metta MG, Moscatiello A, Nannini P, Petruzzi M, Picicco D, Picciotti M, Pisanelli S, Porta N, Ramponi G, Redaelli F, Rubini R, Sala N, Saitta V, Scelza G, Tiso RM, Tomasetto M, Torcoletti M, Travaini M, Valentini M, Vessia C.

Vaccine. 2014 Jan 23;32(5):527-34. doi: 10.1016/j.vaccine.2013.12.003. Epub 2013 Dec 14.

PMID:
24342249
[PubMed - in process]
13.

Serotype distribution of invasive Streptococcus pneumoniae in Canada after the introduction of the 13-valent pneumococcal conjugate vaccine, 2010-2012.

Demczuk WH, Martin I, Griffith A, Lefebvre B, McGeer A, Lovgren M, Tyrrell GJ, Desai S, Sherrard L, Adam H, Gilmour M, Zhanel GG; Toronto Bacterial Diseases Network; Canadian Public Health Laboratory Network.

Can J Microbiol. 2013 Dec;59(12):778-88. doi: 10.1139/cjm-2013-0614. Epub 2013 Oct 21.

PMID:
24313450
[PubMed - indexed for MEDLINE]
14.

Effect of the 13-valent pneumococcal conjugate vaccine on nasopharyngeal colonization by Streptococcus pneumoniae--Alaska, 2008-2012.

Gounder PP, Bruce MG, Bruden DJ, Singleton RJ, Rudolph K, Hurlburt DA, Hennessy TW, Wenger J.

J Infect Dis. 2014 Apr 15;209(8):1251-8. doi: 10.1093/infdis/jit642. Epub 2013 Nov 23.

PMID:
24273178
[PubMed - indexed for MEDLINE]
15.

Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway.

Steens A, Bergsaker MA, Aaberge IS, Rønning K, Vestrheim DF.

Vaccine. 2013 Dec 16;31(52):6232-8. doi: 10.1016/j.vaccine.2013.10.032. Epub 2013 Oct 29.

PMID:
24176490
[PubMed - indexed for MEDLINE]
16.

Cost-effectiveness and cost utility analysis of three pneumococcal conjugate vaccines in children of Peru.

Gomez JA, Tirado JC, Navarro Rojas AA, Castrejon Alba MM, Topachevskyi O.

BMC Public Health. 2013 Oct 30;13:1025. doi: 10.1186/1471-2458-13-1025.

PMID:
24171921
[PubMed - indexed for MEDLINE]
Free Article
17.

Effectiveness of 2+1 PCV7 vaccination schedules in children under 2 years: a meta-analysis of impact studies.

Schönberger K, Kirchgässner K, Riedel C, von Kries R.

Vaccine. 2013 Dec 5;31(50):5948-52. doi: 10.1016/j.vaccine.2013.10.042. Epub 2013 Oct 19. Review.

PMID:
24144469
[PubMed - indexed for MEDLINE]
18.

Experience with pneumococcal polysaccharide conjugate vaccine (conjugated to CRM197 carrier protein) in children and adults.

Durando P, Faust SN, Fletcher M, Krizova P, Torres A, Welte T.

Clin Microbiol Infect. 2013 Oct;19 Suppl 1:1-9. doi: 10.1111/1469-0691.12320. Review.

PMID:
24083785
[PubMed - indexed for MEDLINE]
19.

A mathematical model of serotype replacement in pneumococcal carriage following vaccination.

Bottomley C, Roca A, Hill PC, Greenwood B, Isham V.

J R Soc Interface. 2013 Oct 16;10(89):20130786. doi: 10.1098/rsif.2013.0786. Print 2013 Dec 6.

PMID:
24132203
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Pneumococcal vaccination programs and the burden of invasive pneumococcal disease in Ontario, Canada, 1995-2011.

Rudnick W, Liu Z, Shigayeva A, Low DE, Green K, Plevneshi A, Devlin R, Downey J, Katz K, Kitai I, Krajden S, Ostrowska K, Richardson D, Richardson S, Sarabia A, Silverman M, Simor AE, Tyrrell G, McGeer A; Toronto Invasive Bacterial Diseases Network.

Vaccine. 2013 Dec 2;31(49):5863-71. doi: 10.1016/j.vaccine.2013.09.049. Epub 2013 Oct 5.

PMID:
24099873
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk